ArticleOpen heart2025
Need for a permanent pacemaker after transcatheter aortic valve implantation in Spain: a retrospective analysis of the national Minimum Basic Dataset from 2017 to 2022.
Article in Open heart, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cardioplegia Strategies in Minimally Invasive Aortic Valve Replacement: An Inverse Probability of Treatment Weighting Analysis.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is no available information on the risk of permanent pacemaker implantation following transcatheter aortic valve implantation (TAVI) in Spain. Our objective was to investigate the incidence, temporal trends, and factors associated with this complication between 2017 and 2022, using data from the Spanish National Hospital Discharge Database (CMBD).
methodsThis retrospective study was based on CMBD data of patients who underwent TAVI between 2017 and 2022. Patients under 60 years of age and those with a prior pacemaker or valve prosthesis were excluded. Demographic variables, comorbidities, hospital procedural volume and pacemaker incidence were analysed. A multivariable analysis was performed to evaluate changes in risk over time, adjusted for age, sex and Charlson Comorbidity Index.
resultsA total of 20 826 procedures were included. The overall incidence of pacemaker implantation was 16.8%, increasing from 15.2% in 2017 to 18.2% in 2022 (p<0.001). This increase was independent of age, sex and Charlson index. No modifying effect of hospital procedural volume on the rising pacemaker risk was identified.
conclusionsThe risk of permanent pacemaker implantation after TAVI has increased in Spain between 2017 and 2022. This increase was independent of demographic factors, comorbidities or hospital procedural volume. These findings highlight the need to optimise patient selection and improve TAVI implantation strategies to reduce this complication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.